The combined treatment of these drugs showed effective and synergistic inhibition of tumor growth of an ALDH1+ TNBC xenograft mouse model, by inducing apoptosis, cell cycle arrest, and EMT regulation, with no apparent associated severe toxicity. The gene discussed is ALDH1A1; the disease is neoplasm.